Genetic analysis prohibited without informed consent; exceptions-N.M. Stat. Ann. § 24-21-3

Informed written consent is required prior to obtaining any genetic information or samples from a patient. No genetic information may be collected, retained, transmitted, or used without the informed written consent of the patient. There are, however, several uses of genetic information that may be used without the patient’s informed written consent. Such uses are pursuant to federal or state law and include uses such as identifying a person in the course of a criminal investigation, identifying a deceased individual, and to screen newborns, among other uses. All insurers are exempt from this section for purposes of underwriting that is based on sound actuarial principles.